tiredness Press Release

Title Picture
09/19/2018 - 14:27
Quitting junk food produces similar withdrawal-type symptoms as drug addiction
University of Michigan's picture
University of M...
09/07/2018 - 20:14
Eye movement based metric serving as an on-site test metric for time awake
HelsinkiUniv's picture
HelsinkiUniv
07/20/2018 - 01:13
Vein Health: PAD, DVT and Uterine Artery Embolization
Cone Health's picture
Cone Health
07/18/2018 - 15:25
Novartis Kisqali now first and only CDK4/6 inhibitor indicated in US as first-line therapy specifically for premenopausal women; and as initial therapy with fulvestrant in postmenopausal women
Novartis's picture
Novartis
07/17/2018 - 13:54
Janssen Announces U.S. FDA Approval of SYMTUZATM (D/C/F/TAF), the First and Only Complete Darunavir-Based Single-Tablet Regimen for the Treatment of HIV-1 Infection
Johnson and Johnson's picture
Johnson and Johnson
07/16/2018 - 15:17
Phase 3 CREDENCE Renal Outcomes Trial of INVOKANA (canagliflozin) is Being Stopped Early for Positive Efficacy Findings
Johnson and Johnson's picture
Johnson and Johnson
07/13/2018 - 16:57
U.S. FDA Extends Review Timeline for INVOKANA (canagliflozin) Supplemental New Drug Application
Johnson and Johnson's picture
Johnson and Johnson
07/11/2018 - 03:01
Genentech Announces Submission of Supplemental New Drug Application for Venclexta for People With Previously Untreated Acute Myeloid Leukemia who are Ineligible for Intensive Chemotherapy
Genentech's picture
Genentech
07/02/2018 - 11:53
Council helps residents live a more active and BETTER life with cancer
Cambridge City Council's picture
Cambridge City ...
06/24/2018 - 01:37
Results further characterize the safety and effectiveness of INVOKANA
Johnson and Johnson's picture
Johnson and Johnson
06/23/2018 - 00:55
nearly doubled the likelihood of clinically significant weight loss compared to GLP-1s
Johnson and Johnson's picture
Johnson and Johnson
06/13/2018 - 13:38
Patients to set agenda for heart failure research
University of Bristol's picture
University of B...
06/13/2018 - 11:15
International research team finds brain changes linked to sleep need
UTSouthwestern's picture
UTSouthwestern
06/13/2018 - 11:06
Genentech Announces New Ocrevus (Ocrelizumab) Data on Long-Term Disability Benefits in Primary Progressive Multiple Sclerosis and Initiation of two Global Studies in Progressive MS
Genentech's picture
Genentech
06/08/2018 - 11:19
Genentech Announces FDA Approval for Venclexta Plus Rituxan for People With Previously Treated Chronic Lymphocytic Leukemia
Genentech's picture
Genentech
06/08/2018 - 04:01
Featured Data Includes Findings From OBSERVE-4D the Largest Real-World Study to Evaluate the Risk of Lower Extremity Amputation and Hospitalization for Heart Failure
Johnson and Johnson's picture
Johnson and Johnson
05/29/2018 - 19:34
FDA expedites review of Novartis drug Promacta for first-line severe aplastic anemia (SAA)
Novartis's picture
Novartis
05/13/2018 - 23:20
Suffering mounts as armed groups return to Bambari
MSF's picture
MSF
05/08/2018 - 22:47
Genentech Provides Update on Phase III Study Of TECENTRIQ (Atezolizumab) and COTELLIC (Cobimetinib) in People With Heavily Pre-Treated Locally Advanced or Metastatic Colorectal Cancer
Genentech's picture
Genentech
05/08/2018 - 14:03
Vigorous exercise reduces tiredness in testicular cancer survivors
Cancer Research UK's picture
Cancer Research UK
04/27/2018 - 07:49
Real-World Study Shows INVOKANA (canagliflozin) 300mg Demonstrates Better Blood Glucose Control Than Farxiga (dapagliflozin) 10mg in Patients with Type 2 Diabetes
Johnson and Johnson's picture
Johnson and Johnson
04/24/2018 - 15:35
Four More Mumps Cases Identified, Bringing Total to 19
Delaware State Government's picture
Delaware State ...
04/23/2018 - 08:17
Relapsing MS Patients Who Switched to Aubagio (teriflunomide) Reported Increased Treatment Satisfaction in Two Clinical Studies
Genzyme's picture
Genzyme
04/23/2018 - 06:24
Treatment Effects Maintained over Seven Years in Patients with Relapsing Remitting Multiple Sclerosis Who Received Lemtrada (alemtuzumab) in Clinical Trials
Genzyme's picture
Genzyme
04/21/2018 - 21:37
New OCREVUS (Ocrelizumab) Data at AAN Demonstrate Significant Reductions in Disease Activity and Disability Progression in Relapsing Multiple Sclerosis
Genentech's picture
Genentech
04/15/2018 - 00:14
Genentech to Present New Data at AAN Highlighting Extensive Research for Ocrevus and Expanding Neuroscience Pipeline
Genentech's picture
Genentech
04/13/2018 - 01:32
MUMPS CASES RISE TO 15
DHSS's picture
DHSS
04/12/2018 - 04:51
INVOKANA (canagliflozin) Demonstrated Significant Renal Protective Benefits in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease
Johnson and Johnson's picture
Johnson and Johnson
04/06/2018 - 14:57
DPH ANNOUNCES ADDITIONAL MUMPS CASES
DHSS's picture
DHSS
03/29/2018 - 12:10
Mumps Cases Increase to 11; Possible Link to Second Mexican Dance Event at Chase Center
Delaware State Government's picture
Delaware State ...
03/28/2018 - 12:12
Mumps Cases Increase to Nine; Possible Link to Second Mexican Dance Event at Chase Center
Delaware State Government's picture
Delaware State ...
03/23/2018 - 01:09
Shingrix approved in Europe and Japan for the prevention of shingles in adults aged 50 and over
GlaxoSmithKline's picture
GlaxoSmithKline
03/22/2018 - 15:08
DPH Investigating Mumps Outbreak After February Baile Mejicano Dance at Chase Center on the Riverfront
Delaware State Government's picture
Delaware State ...
03/11/2018 - 15:59
Late-breaking exploratory analysis from the CANVAS Program presented at the American College of Cardiologys 67
Johnson and Johnson's picture
Johnson and Johnson
03/08/2018 - 23:42
Red Devils looking to forget Palace fright
Betfair's picture
Betfair
02/05/2018 - 11:01
Mice and humans share sleep disorders - fundamental mechanisms of sleep are similar regardless of species
HelsinkiUniv's picture
HelsinkiUniv
01/26/2018 - 01:05
GSKs Shingrix receives positive opinion from the CHMP in Europe for the prevention of shingles in adults aged 50 and over
GlaxoSmithKline's picture
GlaxoSmithKline
12/11/2017 - 21:47
How to care for children with chickenpox
AAD's picture
AAD
12/10/2017 - 10:49
Phase II Data Showed Genentechs Investigational Polatuzumab Vedotin Plus Bendamustine and Rituxan (BR) Increased Complete Response Rates Compared to BR Alone in Previously Treated Aggressive Lymphoma
Genentech's picture
Genentech
11/17/2017 - 13:15
EASEL is the first real-world study to show adults with type 2 diabetes and established cardiovascular disease (CVD) have a lower risk of major adverse cardiovascular events (MACE) with SGLT2i therapy
Johnson and Johnson's picture
Johnson and Johnson
11/16/2017 - 14:21
FDA Approves Genentechs Gazyva for Previously Untreated Advanced Follicular Lymphoma
Genentech's picture
Genentech
11/14/2017 - 08:56
INVOKANA (canagliflozin) Demonstrates Cardiovascular (CV) Risk Reductions in Type 2 Diabetes Patients With and Without a History of Prior CV Events
Johnson and Johnson's picture
Johnson and Johnson
11/06/2017 - 08:49
STELARA (USTEKINUMAB) SHOWS POSITIVE RESULTS IN TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS IN PHASE 2 TRIAL
Johnson and Johnson's picture
Johnson and Johnson
11/03/2017 - 11:28
INVOKANA (canagliflozin) Significantly Improved Renal Outcomes and Demonstrated Potential Renal Protective Effects in Patients with Type 2 Diabetes Who Have or Are at Risk for Cardiovascular Disease
Johnson and Johnson's picture
Johnson and Johnson
10/29/2017 - 19:32
One Year Maintenance and Switching Data in Patients with Crohns Disease Support the Use of INFLECTRA* (infliximab CT-P13) in IBD1
Pfizer's picture
Pfizer
10/27/2017 - 05:58
Treatment Effects Maintained Over Five Years in Patients with Relapsing Remitting Multiple Sclerosis who Received Sanofi Genzymes Lemtrada (alemtuzumab) in Extension Study After Switching from Interferon Beta-1a
Genzyme's picture
Genzyme
10/26/2017 - 07:49
New Data Suggest Slowing of Cortical Gray Matter Atrophy with Sanofi Genzymes Aubagio (teriflunomide) is Associated with Delayed Conversion to Clinically Definite Multiple Sclerosis
Genzyme's picture
Genzyme
10/26/2017 - 02:12
New OCREVUS (Ocrelizumab) Data at ECTRIMS Advance Clinical Understanding of Underlying Progression in Multiple Sclerosis
Genentech's picture
Genentech
10/25/2017 - 12:52
CDCs Advisory Committee on Immunization Practices recommends Shingrix as the preferred vaccine for the prevention of shingles for adults aged 50 and up
GlaxoSmithKline's picture
GlaxoSmithKline
10/20/2017 - 16:32
Shingrix approved in the US for prevention of shingles in adults aged 50 and over
GlaxoSmithKline's picture
GlaxoSmithKline
10/18/2017 - 05:51
High blood pressure linked to common heart valve disorder
UniversityOfOxford's picture
UniversityOfOxford
10/17/2017 - 09:36
More than 30 Presentations of New Investigational Data from Sanofi Genzymes Multiple Sclerosis Franchise to be Featured at ECTRIMS-ACTRIMS
Genzyme's picture
Genzyme
10/14/2017 - 22:41
Genentech to Present New Ocrevus (Ocrelizumab) Efficacy & Safety Data in Relapsing and Primary Progressive Forms of Multiple Sclerosis at ECTRIMS
Genentech's picture
Genentech
10/13/2017 - 16:36
American Thyroid Association: Presentations at 87th Annual Meeting Regarding Medications and Their Effects ATA Abstracts
American Thyroid Association's picture
American Thyroi...
10/12/2017 - 20:36
JANSSEN ANNOUNCES U.S. FDA APPROVAL OF STELARA (USTEKINUMAB) FOR THE TREATMENT OF ADOLESCENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS
Johnson and Johnson's picture
Johnson and Johnson
10/12/2017 - 08:12
Ortho Dermatologics Announces Two-Year Findings From Pivotal Phase 3 Study Of SILIQ (brodalumab) Injection Data Demonstrating Long-Term Efficacy Profile
Valeant Pharmaceuticals's picture
Valeant Pharmac...
10/12/2017 - 07:36
U.S. FDA Approves LYRICA CR (pregabalin) Extended-Release Tablets CV
Pfizer's picture
Pfizer
10/02/2017 - 08:39
Janssen Submits Supplemental New Drug Application (sNDA) to U.S. FDA Seeking New Indication for INVOKANA (canagliflozin) to Reduce the Risk of Major Adverse Cardiovascular Events (MACE) Based on Landmark CANVAS Program
Johnson and Johnson's picture
Johnson and Johnson
09/12/2017 - 10:52
US Oncology Research Plays an Important Role in the Clinical Development for NERLYNX (Neratinib) Tablets
McKesson's picture
McKesson
08/27/2017 - 00:54
FDA Grants Priority Review for Genentechs Gazyva in Previously Untreated Follicular Lymphoma
Genentech's picture
Genentech